+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Echinocandin B Market - Global Forecast 2026-2032- Product Image
Echinocandin B Market - Global Forecast 2026-2032- Product Image
Sale

Echinocandin B Market - Global Forecast 2026-2032

  • Report

  • 186 Pages
  • September 2026
  • Region: Global
  • 360iResearch™
  • ID: 6127612
UP TO OFF until Jan 01st 2027
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.
The Echinocandin B Market is projected to reach USD 305.95 Million in 2026. It is expected to continue growing at a CAGR of 12.54%, reaching USD 612.34 Million by 2032.

Echinocandin B: Executive Summary Scope and Context

Echinocandin B is a cyclic lipopeptide of scientific interest because it provides a structural and biosynthetic reference point for the echinocandin class of antifungal agents. Its relevance spans natural-product chemistry, fungal biology, medicinal chemistry, analytical characterization, and pharmaceutical research. This summary focuses on evidence-based landscape developments, regional and country-level considerations, and practical priorities for organizations working with the compound or related research programs. It does not provide market estimates, forecasts, market shares, or company-specific analysis.

From Natural-Product Reference to Advanced Antifungal Research

Research involving Echinocandin B reflects broader shifts in antifungal development: greater attention to fungal cell-wall biology, improved characterization of complex natural products, and rising emphasis on reproducible manufacturing and quality control. The compound’s relationship to echinocandin pharmacology makes structure-activity relationships, impurity profiling, formulation science, and resistance biology important areas of investigation. Progress increasingly depends on connecting laboratory evidence with regulatory-quality documentation, robust analytical methods, and responsible stewardship of antifungal use.

Artificial Intelligence Accelerates Discovery, Characterization, and Quality Workflows

Artificial intelligence can support Echinocandin B research by prioritizing biosynthetic pathways, predicting molecular properties, identifying analytical signals, and helping researchers compare structure-activity datasets. Machine-learning tools may also assist strain selection, fermentation optimization, spectral interpretation, and early screening for resistance-associated patterns. These applications remain dependent on high-quality training data, experimentally validated predictions, transparent model performance, and controls against bias or overinterpretation. Human review, orthogonal analytical confirmation, and compliance with applicable research and manufacturing standards remain essential.

Regional Insights: Capabilities Differ Across the Antifungal Research Ecosystem

North America combines strong biomedical research capacity with established translational and regulatory infrastructure, supporting advanced antifungal biology and analytical development. Europe emphasizes coordinated research, quality systems, and stewardship, with the European Union providing an important framework for cross-border scientific and regulatory collaboration. Asia-Pacific includes substantial pharmaceutical, biotechnology, and academic capabilities, alongside varied access to specialized instrumentation and biological resources. Latin America is strengthening infectious-disease research and laboratory networks, while differences in funding and procurement can affect continuity. The Middle East is expanding healthcare and research capacity through selected institutional programs, and Africa faces persistent infrastructure and access constraints while offering important priorities for fungal-disease surveillance, diagnostics, and locally relevant research.

Group Insights: Alliances Shape Standards, Access, and Research Coordination

ASEAN cooperation is relevant to regional laboratory networks, manufacturing capabilities, and harmonization efforts across diverse health systems. BRICS members bring substantial scientific, industrial, and public-health capacity but operate under varied regulatory and research environments. The European Union supports coordinated standards, multicountry studies, and shared scientific programs. G7 countries contribute influential research, regulatory, and stewardship practices, while GCC states are developing healthcare and biomedical infrastructure through national investment programs. NATO members may influence preparedness-oriented research coordination and scientific collaboration, although the group is not a unified pharmaceutical market or regulatory authority.

Country Insights: National Strengths and Constraints Affect Research Execution

Australia supports advanced biomedical research and university-led discovery, with geographic distance influencing specialized supply chains. Brazil combines substantial academic and public-health expertise with regional manufacturing potential, while Canada offers strong research institutions and a structured regulatory environment. China and India provide large scientific workforces, expanding bioprocessing capabilities, and diverse research ecosystems. France, Germany, Italy, Spain, and the United Kingdom contribute established pharmaceutical science, clinical research, and regulatory expertise within broader European networks. Japan and South Korea are notable for advanced biotechnology, analytical science, and manufacturing capabilities. The United States remains important for antifungal research, translational development, and regulatory science. Mexico is strengthening pharmaceutical and laboratory capacity. Russia maintains scientific capabilities but may face constraints related to international collaboration, equipment access, and supply continuity.

Actionable Priorities for Echinocandin B Research and Development Leaders

Leaders should establish a traceable chain from source material and biosynthetic production through identity, purity, potency, and stability testing. They should use orthogonal analytical methods, define reference standards clearly, and document sample handling to improve reproducibility across laboratories. Research programs should connect mechanism-of-action studies with resistance surveillance and clinically relevant fungal models. Artificial intelligence should be deployed selectively, with curated datasets, predefined validation criteria, and expert review. Organizations should also diversify critical inputs, assess regional regulatory requirements early, strengthen collaboration with specialized laboratories, and align development decisions with antifungal stewardship and equitable access objectives.

Research Methodology: Evidence-Led Synthesis Without Market Estimation

This executive summary uses the supplied market reference only to identify Echinocandin B as the subject. The analysis is structured as a qualitative synthesis of established scientific, regulatory, manufacturing, regional, and public-health considerations associated with the compound and the wider echinocandin research context. It integrates the requested regions, country groups, and countries without assigning numerical market values, shares, forecasts, or estimates. Interpretations should be validated against current primary literature, official regulatory publications, pharmacopoeial standards, public-health guidance, and institution-specific data before operational decisions are made.

Conclusion: Build Evidence, Resilience, and Responsible Antifungal Innovation

Echinocandin B remains relevant as a reference molecule for understanding natural-product antifungal chemistry and the scientific foundations of echinocandin-related research. The most durable opportunities lie in better biosynthetic control, stronger analytical reproducibility, validated computational assistance, resistance-aware development, and collaboration across regions with different capabilities. Industry leaders that combine rigorous evidence generation with resilient supply planning, regulatory discipline, and stewardship principles will be better positioned to translate research on Echinocandin B and related compounds into credible scientific and health outcomes.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Definition
1.3. Market Segmentation & Coverage
1.4. Years Considered for the Study
1.5. Currency Considered for the Study
1.6. Language Considered for the Study
1.7. Key Stakeholders
2. Research Methodology
2.1. Introduction
2.2. Research Design
2.2.1. Primary Research
2.2.2. Secondary Research
2.3. Research Framework
2.3.1. Qualitative Analysis
2.3.2. Quantitative Analysis
2.4. Market Size Estimation
2.4.1. Top-Down Approach
2.4.2. Bottom-Up Approach
2.5. Data Triangulation
2.6. Research Outcomes
2.7. Research Assumptions
2.8. Research Limitations
3. Executive Summary
3.1. Introduction
3.2. CXO Perspective
3.3. New Revenue Opportunities
3.4. Next-Generation Business Models
3.5. Industry Roadmap
4. Market Overview
4.1. Introduction
4.2. Industry Ecosystem & Value Chain Analysis
4.2.1. Supply-Side Analysis
4.2.2. Demand-Side Analysis
4.2.3. Stakeholder Analysis
4.3. Market Dynamics
4.3.1. Key Drivers
4.3.2. Key Restraints
4.3.3. Key Opportunities
4.3.4. Key Challenges
4.4. Porter’s Five Forces Analysis
4.5. PESTLE Analysis
4.6. Market Outlook
4.6.1. Near-Term Market Outlook (0-2 Years)
4.6.2. Medium-Term Market Outlook (3-5 Years)
4.6.3. Long-Term Market Outlook (5-10 Years)
4.7. Go-to-Market Strategy
5. Market Insights
5.1. Consumer Insights & End-User Perspective
5.2. Consumer Experience Benchmarking
5.3. Opportunity Mapping
5.4. Distribution Channel Analysis
5.5. Pricing Trend Analysis
5.6. Regulatory Compliance & Standards Framework
5.7. ESG & Sustainability Analysis
5.8. Disruption & Risk Scenarios
5.9. Return on Investment & Cost-Benefit Analysis
6. Cumulative Impact of Artificial Intelligence 2026
7. Echinocandin B Market, by Product Type
7.1. Introduction
7.2. Active Pharmaceutical Ingredient (API)
7.2.1. Crude Echinocandin B
7.2.2. Purified Echinocandin B
7.3. Intermediate For Derivatives
7.3.1. Caspofungin Intermediate
7.3.2. Micafungin Intermediate
7.3.3. Anidulafungin Intermediate
7.4. Finished Dosage Form
7.4.1. Injectable Formulations
7.4.2. Oral Formulations
7.5. Reference Standard
7.6. Custom Synthesis
8. Echinocandin B Market, by Route Of Administration
8.1. Introduction
8.2. Intravenous
8.2.1. Continuous Infusion
8.2.2. Intermittent Infusion
9. Echinocandin B Market, by Formulation
9.1. Introduction
9.2. Lyophilized Powder
9.2.1. Manual Reconstitution
9.2.2. Ready To Reconstitute
9.3. Prefilled Syringe
10. Echinocandin B Market, by Dosage Regimen
10.1. Introduction
10.2. Once Daily
10.2.1. High Dose
10.2.2. Standard Dose
10.3. Twice Daily
10.3.1. High Dose
10.3.2. Standard Dose
11. Echinocandin B Market, by Packaging
11.1. Introduction
11.2. Multi Dose Packaging
11.3. Single Dose Packaging
12. Echinocandin B Market, by Distribution Channel
12.1. Introduction
12.2. Hospital Pharmacy
12.2.1. Direct Tender
12.2.2. Third Party Tender
12.3. Online Pharmacy
12.4. Retail Pharmacy
13. Echinocandin B Market, by Application
13.1. Introduction
13.2. Therapeutic Development
13.2.1. Antifungal Drug Development
13.2.2. Combination Therapy Development
13.3. Commercial Production
13.3.1. Bulk Drug Manufacturing
13.3.2. Formulation Manufacturing
13.4. Research & Development
13.4.1. Mechanistic Studies
13.4.2. Resistance Profiling
13.4.3. Pharmacokinetic Studies
13.4.4. Toxicology Studies
13.5. Quality Control & Analytics
13.5.1. Reference Standards
13.5.2. Assay Calibration
13.5.3. Stability Testing
13.6. Diagnostic Use
13.6.1. Fungal Susceptibility Testing
13.6.2. Biomarker Assay Development
14. Echinocandin B Market, by End User
14.1. Introduction
14.2. Pharmaceutical & Biotechnology Companies
14.2.1. Branded Drug Manufacturers
14.2.2. Generic Drug Manufacturers
14.2.3. Contract Manufacturing Organizations
14.3. Contract Research Organizations
14.4. Academic & Research Institutes
14.5. Diagnostic Laboratories
14.6. Government & Nonprofit Research Bodies
15. Echinocandin B Market, by Region
15.1. Introduction
15.2. Asia-Pacific
15.3. North America
15.4. Latin America
15.5. Europe
15.6. Middle East
15.7. Africa
16. Echinocandin B Market, by Group
16.1. Introduction
16.2. ASEAN
16.3. GCC
16.4. European Union
16.5. BRICS
16.6. G7
16.7. NATO
17. Echinocandin B Market, by Country
17.1. Introduction
17.2. United States
17.3. Canada
17.4. Mexico
17.5. Brazil
17.6. United Kingdom
17.7. Germany
17.8. France
17.9. Russia
17.10. Italy
17.11. Spain
17.12. China
17.13. India
17.14. Japan
17.15. Australia
17.16. South Korea
18. Competitive Landscape
18.1. Market Share Analysis, 2025
18.2. Market Concentration Analysis, 2025
18.2.1. Concentration Ratio (CR)
18.2.2. Herfindahl Hirschman Index (HHI)
18.3. Recent Developments & Impact Analysis, 2025
18.4. Product Portfolio Analysis, 2025
18.5. Benchmarking Analysis, 2025
19. Company Profiles
19.1. Amneal Pharmaceuticals, Inc.
19.2. Apotex Inc.
19.3. Astellas Pharma Inc.
19.4. Cipla Limited
19.5. Dr. Reddy’s Laboratories Ltd.
19.6. F. Hoffmann-La Roche Ltd.
19.7. Fresenius SE & Co. KGaA
19.8. Gilead Sciences, Inc.
19.9. GlaxoSmithKline plc
19.10. Glenmark Pharmaceuticals Ltd.
19.11. Hikma Pharmaceuticals PLC
19.12. Merck & Co., Inc.
19.13. Novartis AG
19.14. Pfizer Inc.
19.15. Sanofi
19.16. Sun Pharmaceutical Industries Ltd.
19.17. Teva Pharmaceutical Industries Ltd.
19.18. Viatris Inc.
19.19. Wockhardt Limited
19.20. Zydus Lifesciences Limited
20. Key Experts
LIST OF FIGURES
FIGURE 1. Global Echinocandin B Market, Years Considered for the Study
FIGURE 2. Global Echinocandin B Market, Research Design
FIGURE 3. Global Echinocandin B Market, Research Framework
FIGURE 4. Global Echinocandin B Market, Data Triangulation
FIGURE 5. Global Echinocandin B Market Size, 2017-2032 (USD Million)
FIGURE 6. Global Echinocandin B Market Size, by Product Type, 2025 vs 2032 (%)
FIGURE 7. Global Echinocandin B Market Size, by Product Type, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 8. Global Echinocandin B Market Size, by Route Of Administration, 2025 vs 2032 (%)
FIGURE 9. Global Echinocandin B Market Size, by Route Of Administration, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 10. Global Echinocandin B Market Size, by Formulation, 2025 vs 2032 (%)
FIGURE 11. Global Echinocandin B Market Size, by Formulation, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 12. Global Echinocandin B Market Size, by Dosage Regimen, 2025 vs 2032 (%)
FIGURE 13. Global Echinocandin B Market Size, by Dosage Regimen, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 14. Global Echinocandin B Market Size, by Packaging, 2025 vs 2032 (%)
FIGURE 15. Global Echinocandin B Market Size, by Packaging, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 16. Global Echinocandin B Market Size, by Distribution Channel, 2025 vs 2032 (%)
FIGURE 17. Global Echinocandin B Market Size, by Distribution Channel, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 18. Global Echinocandin B Market Size, by Application, 2025 vs 2032 (%)
FIGURE 19. Global Echinocandin B Market Size, by Application, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 20. Global Echinocandin B Market Size, by End User, 2025 vs 2032 (%)
FIGURE 21. Global Echinocandin B Market Size, by End User, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 22. Global Echinocandin B Market Size, by Region, 2025 vs 2032 (%)
FIGURE 23. Global Echinocandin B Market Size, by Region, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 24. Global Echinocandin B Market Size, by Group, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 25. Global Echinocandin B Market Size, by Country, 2025 vs 2032 (%)
FIGURE 26. Global Echinocandin B Market Size, by Country, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 27. Global Echinocandin B Market Share, by Key Player, 2025
LIST OF TABLES
TABLE 1. Global Echinocandin B Market Segmentation & Coverage
TABLE 2. Global Echinocandin B Market Size, 2017-2032 (USD Million)
TABLE 3. Global Echinocandin B Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 4. Global Active Pharmaceutical Ingredient (API) Market Size, by Region, 2017-2032 (USD Million)
TABLE 5. Global Active Pharmaceutical Ingredient (API) Market Size, by Group, 2017-2032 (USD Million)
TABLE 6. Global Active Pharmaceutical Ingredient (API) Market Size, by Country, 2017-2032 (USD Million)
TABLE 7. Global Crude Echinocandin B Market Size, by Region, 2017-2032 (USD Million)
TABLE 8. Global Crude Echinocandin B Market Size, by Group, 2017-2032 (USD Million)
TABLE 9. Global Crude Echinocandin B Market Size, by Country, 2017-2032 (USD Million)
TABLE 10. Global Purified Echinocandin B Market Size, by Region, 2017-2032 (USD Million)
TABLE 11. Global Purified Echinocandin B Market Size, by Group, 2017-2032 (USD Million)
TABLE 12. Global Purified Echinocandin B Market Size, by Country, 2017-2032 (USD Million)
TABLE 13. Global Intermediate For Derivatives Market Size, by Region, 2017-2032 (USD Million)
TABLE 14. Global Intermediate For Derivatives Market Size, by Group, 2017-2032 (USD Million)
TABLE 15. Global Intermediate For Derivatives Market Size, by Country, 2017-2032 (USD Million)
TABLE 16. Global Caspofungin Intermediate Market Size, by Region, 2017-2032 (USD Million)
TABLE 17. Global Caspofungin Intermediate Market Size, by Group, 2017-2032 (USD Million)
TABLE 18. Global Caspofungin Intermediate Market Size, by Country, 2017-2032 (USD Million)
TABLE 19. Global Micafungin Intermediate Market Size, by Region, 2017-2032 (USD Million)
TABLE 20. Global Micafungin Intermediate Market Size, by Group, 2017-2032 (USD Million)
TABLE 21. Global Micafungin Intermediate Market Size, by Country, 2017-2032 (USD Million)
TABLE 22. Global Anidulafungin Intermediate Market Size, by Region, 2017-2032 (USD Million)
TABLE 23. Global Anidulafungin Intermediate Market Size, by Group, 2017-2032 (USD Million)
TABLE 24. Global Anidulafungin Intermediate Market Size, by Country, 2017-2032 (USD Million)
TABLE 25. Global Finished Dosage Form Market Size, by Region, 2017-2032 (USD Million)
TABLE 26. Global Finished Dosage Form Market Size, by Group, 2017-2032 (USD Million)
TABLE 27. Global Finished Dosage Form Market Size, by Country, 2017-2032 (USD Million)
TABLE 28. Global Injectable Formulations Market Size, by Region, 2017-2032 (USD Million)
TABLE 29. Global Injectable Formulations Market Size, by Group, 2017-2032 (USD Million)
TABLE 30. Global Injectable Formulations Market Size, by Country, 2017-2032 (USD Million)
TABLE 31. Global Oral Formulations Market Size, by Region, 2017-2032 (USD Million)
TABLE 32. Global Oral Formulations Market Size, by Group, 2017-2032 (USD Million)
TABLE 33. Global Oral Formulations Market Size, by Country, 2017-2032 (USD Million)
TABLE 34. Global Reference Standard Market Size, by Region, 2017-2032 (USD Million)
TABLE 35. Global Reference Standard Market Size, by Group, 2017-2032 (USD Million)
TABLE 36. Global Reference Standard Market Size, by Country, 2017-2032 (USD Million)
TABLE 37. Global Custom Synthesis Market Size, by Region, 2017-2032 (USD Million)
TABLE 38. Global Custom Synthesis Market Size, by Group, 2017-2032 (USD Million)
TABLE 39. Global Custom Synthesis Market Size, by Country, 2017-2032 (USD Million)
TABLE 40. Global Echinocandin B Market Size, by Route Of Administration, 2017-2032 (USD Million)
TABLE 41. Global Intravenous Market Size, by Region, 2017-2032 (USD Million)
TABLE 42. Global Intravenous Market Size, by Group, 2017-2032 (USD Million)
TABLE 43. Global Intravenous Market Size, by Country, 2017-2032 (USD Million)
TABLE 44. Global Continuous Infusion Market Size, by Region, 2017-2032 (USD Million)
TABLE 45. Global Continuous Infusion Market Size, by Group, 2017-2032 (USD Million)
TABLE 46. Global Continuous Infusion Market Size, by Country, 2017-2032 (USD Million)
TABLE 47. Global Intermittent Infusion Market Size, by Region, 2017-2032 (USD Million)
TABLE 48. Global Intermittent Infusion Market Size, by Group, 2017-2032 (USD Million)
TABLE 49. Global Intermittent Infusion Market Size, by Country, 2017-2032 (USD Million)
TABLE 50. Global Echinocandin B Market Size, by Formulation, 2017-2032 (USD Million)
TABLE 51. Global Lyophilized Powder Market Size, by Region, 2017-2032 (USD Million)
TABLE 52. Global Lyophilized Powder Market Size, by Group, 2017-2032 (USD Million)
TABLE 53. Global Lyophilized Powder Market Size, by Country, 2017-2032 (USD Million)
TABLE 54. Global Manual Reconstitution Market Size, by Region, 2017-2032 (USD Million)
TABLE 55. Global Manual Reconstitution Market Size, by Group, 2017-2032 (USD Million)
TABLE 56. Global Manual Reconstitution Market Size, by Country, 2017-2032 (USD Million)
TABLE 57. Global Ready To Reconstitute Market Size, by Region, 2017-2032 (USD Million)
TABLE 58. Global Ready To Reconstitute Market Size, by Group, 2017-2032 (USD Million)
TABLE 59. Global Ready To Reconstitute Market Size, by Country, 2017-2032 (USD Million)
TABLE 60. Global Prefilled Syringe Market Size, by Region, 2017-2032 (USD Million)
TABLE 61. Global Prefilled Syringe Market Size, by Group, 2017-2032 (USD Million)
TABLE 62. Global Prefilled Syringe Market Size, by Country, 2017-2032 (USD Million)
TABLE 63. Global Echinocandin B Market Size, by Dosage Regimen, 2017-2032 (USD Million)
TABLE 64. Global Once Daily Market Size, by Region, 2017-2032 (USD Million)
TABLE 65. Global Once Daily Market Size, by Group, 2017-2032 (USD Million)
TABLE 66. Global Once Daily Market Size, by Country, 2017-2032 (USD Million)
TABLE 67. Global High Dose Market Size, by Region, 2017-2032 (USD Million)
TABLE 68. Global High Dose Market Size, by Group, 2017-2032 (USD Million)
TABLE 69. Global High Dose Market Size, by Country, 2017-2032 (USD Million)
TABLE 70. Global Standard Dose Market Size, by Region, 2017-2032 (USD Million)
TABLE 71. Global Standard Dose Market Size, by Group, 2017-2032 (USD Million)
TABLE 72. Global Standard Dose Market Size, by Country, 2017-2032 (USD Million)
TABLE 73. Global Twice Daily Market Size, by Region, 2017-2032 (USD Million)
TABLE 74. Global Twice Daily Market Size, by Group, 2017-2032 (USD Million)
TABLE 75. Global Twice Daily Market Size, by Country, 2017-2032 (USD Million)
TABLE 76. Global High Dose Market Size, by Region, 2017-2032 (USD Million)
TABLE 77. Global High Dose Market Size, by Group, 2017-2032 (USD Million)
TABLE 78. Global High Dose Market Size, by Country, 2017-2032 (USD Million)
TABLE 79. Global Standard Dose Market Size, by Region, 2017-2032 (USD Million)
TABLE 80. Global Standard Dose Market Size, by Group, 2017-2032 (USD Million)
TABLE 81. Global Standard Dose Market Size, by Country, 2017-2032 (USD Million)
TABLE 82. Global Echinocandin B Market Size, by Packaging, 2017-2032 (USD Million)
TABLE 83. Global Multi Dose Packaging Market Size, by Region, 2017-2032 (USD Million)
TABLE 84. Global Multi Dose Packaging Market Size, by Group, 2017-2032 (USD Million)
TABLE 85. Global Multi Dose Packaging Market Size, by Country, 2017-2032 (USD Million)
TABLE 86. Global Single Dose Packaging Market Size, by Region, 2017-2032 (USD Million)
TABLE 87. Global Single Dose Packaging Market Size, by Group, 2017-2032 (USD Million)
TABLE 88. Global Single Dose Packaging Market Size, by Country, 2017-2032 (USD Million)
TABLE 89. Global Echinocandin B Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 90. Global Hospital Pharmacy Market Size, by Region, 2017-2032 (USD Million)
TABLE 91. Global Hospital Pharmacy Market Size, by Group, 2017-2032 (USD Million)
TABLE 92. Global Hospital Pharmacy Market Size, by Country, 2017-2032 (USD Million)
TABLE 93. Global Direct Tender Market Size, by Region, 2017-2032 (USD Million)
TABLE 94. Global Direct Tender Market Size, by Group, 2017-2032 (USD Million)
TABLE 95. Global Direct Tender Market Size, by Country, 2017-2032 (USD Million)
TABLE 96. Global Third Party Tender Market Size, by Region, 2017-2032 (USD Million)
TABLE 97. Global Third Party Tender Market Size, by Group, 2017-2032 (USD Million)
TABLE 98. Global Third Party Tender Market Size, by Country, 2017-2032 (USD Million)
TABLE 99. Global Online Pharmacy Market Size, by Region, 2017-2032 (USD Million)
TABLE 100. Global Online Pharmacy Market Size, by Group, 2017-2032 (USD Million)
TABLE 101. Global Online Pharmacy Market Size, by Country, 2017-2032 (USD Million)
TABLE 102. Global Retail Pharmacy Market Size, by Region, 2017-2032 (USD Million)
TABLE 103. Global Retail Pharmacy Market Size, by Group, 2017-2032 (USD Million)
TABLE 104. Global Retail Pharmacy Market Size, by Country, 2017-2032 (USD Million)
TABLE 105. Global Echinocandin B Market Size, by Application, 2017-2032 (USD Million)
TABLE 106. Global Therapeutic Development Market Size, by Region, 2017-2032 (USD Million)
TABLE 107. Global Therapeutic Development Market Size, by Group, 2017-2032 (USD Million)
TABLE 108. Global Therapeutic Development Market Size, by Country, 2017-2032 (USD Million)
TABLE 109. Global Antifungal Drug Development Market Size, by Region, 2017-2032 (USD Million)
TABLE 110. Global Antifungal Drug Development Market Size, by Group, 2017-2032 (USD Million)
TABLE 111. Global Antifungal Drug Development Market Size, by Country, 2017-2032 (USD Million)
TABLE 112. Global Combination Therapy Development Market Size, by Region, 2017-2032 (USD Million)
TABLE 113. Global Combination Therapy Development Market Size, by Group, 2017-2032 (USD Million)
TABLE 114. Global Combination Therapy Development Market Size, by Country, 2017-2032 (USD Million)
TABLE 115. Global Commercial Production Market Size, by Region, 2017-2032 (USD Million)
TABLE 116. Global Commercial Production Market Size, by Group, 2017-2032 (USD Million)
TABLE 117. Global Commercial Production Market Size, by Country, 2017-2032 (USD Million)
TABLE 118. Global Bulk Drug Manufacturing Market Size, by Region, 2017-2032 (USD Million)
TABLE 119. Global Bulk Drug Manufacturing Market Size, by Group, 2017-2032 (USD Million)
TABLE 120. Global Bulk Drug Manufacturing Market Size, by Country, 2017-2032 (USD Million)
TABLE 121. Global Formulation Manufacturing Market Size, by Region, 2017-2032 (USD Million)
TABLE 122. Global Formulation Manufacturing Market Size, by Group, 2017-2032 (USD Million)
TABLE 123. Global Formulation Manufacturing Market Size, by Country, 2017-2032 (USD Million)
TABLE 124. Global Research & Development Market Size, by Region, 2017-2032 (USD Million)
TABLE 125. Global Research & Development Market Size, by Group, 2017-2032 (USD Million)
TABLE 126. Global Research & Development Market Size, by Country, 2017-2032 (USD Million)
TABLE 127. Global Mechanistic Studies Market Size, by Region, 2017-2032 (USD Million)
TABLE 128. Global Mechanistic Studies Market Size, by Group, 2017-2032 (USD Million)
TABLE 129. Global Mechanistic Studies Market Size, by Country, 2017-2032 (USD Million)
TABLE 130. Global Resistance Profiling Market Size, by Region, 2017-2032 (USD Million)
TABLE 131. Global Resistance Profiling Market Size, by Group, 2017-2032 (USD Million)
TABLE 132. Global Resistance Profiling Market Size, by Country, 2017-2032 (USD Million)
TABLE 133. Global Pharmacokinetic Studies Market Size, by Region, 2017-2032 (USD Million)
TABLE 134. Global Pharmacokinetic Studies Market Size, by Group, 2017-2032 (USD Million)
TABLE 135. Global Pharmacokinetic Studies Market Size, by Country, 2017-2032 (USD Million)
TABLE 136. Global Toxicology Studies Market Size, by Region, 2017-2032 (USD Million)
TABLE 137. Global Toxicology Studies Market Size, by Group, 2017-2032 (USD Million)
TABLE 138. Global Toxicology Studies Market Size, by Country, 2017-2032 (USD Million)
TABLE 139. Global Quality Control & Analytics Market Size, by Region, 2017-2032 (USD Million)
TABLE 140. Global Quality Control & Analytics Market Size, by Group, 2017-2032 (USD Million)
TABLE 141. Global Quality Control & Analytics Market Size, by Country, 2017-2032 (USD Million)
TABLE 142. Global Reference Standards Market Size, by Region, 2017-2032 (USD Million)
TABLE 143. Global Reference Standards Market Size, by Group, 2017-2032 (USD Million)
TABLE 144. Global Reference Standards Market Size, by Country, 2017-2032 (USD Million)
TABLE 145. Global Assay Calibration Market Size, by Region, 2017-2032 (USD Million)
TABLE 146. Global Assay Calibration Market Size, by Group, 2017-2032 (USD Million)
TABLE 147. Global Assay Calibration Market Size, by Country, 2017-2032 (USD Million)
TABLE 148. Global Stability Testing Market Size, by Region, 2017-2032 (USD Million)
TABLE 149. Global Stability Testing Market Size, by Group, 2017-2032 (USD Million)
TABLE 150. Global Stability Testing Market Size, by Country, 2017-2032 (USD Million)
TABLE 151. Global Diagnostic Use Market Size, by Region, 2017-2032 (USD Million)
TABLE 152. Global Diagnostic Use Market Size, by Group, 2017-2032 (USD Million)
TABLE 153. Global Diagnostic Use Market Size, by Country, 2017-2032 (USD Million)
TABLE 154. Global Fungal Susceptibility Testing Market Size, by Region, 2017-2032 (USD Million)
TABLE 155. Global Fungal Susceptibility Testing Market Size, by Group, 2017-2032 (USD Million)
TABLE 156. Global Fungal Susceptibility Testing Market Size, by Country, 2017-2032 (USD Million)
TABLE 157. Global Biomarker Assay Development Market Size, by Region, 2017-2032 (USD Million)
TABLE 158. Global Biomarker Assay Development Market Size, by Group, 2017-2032 (USD Million)
TABLE 159. Global Biomarker Assay Development Market Size, by Country, 2017-2032 (USD Million)
TABLE 160. Global Echinocandin B Market Size, by End User, 2017-2032 (USD Million)
TABLE 161. Global Pharmaceutical & Biotechnology Companies Market Size, by Region, 2017-2032 (USD Million)
TABLE 162. Global Pharmaceutical & Biotechnology Companies Market Size, by Group, 2017-2032 (USD Million)
TABLE 163. Global Pharmaceutical & Biotechnology Companies Market Size, by Country, 2017-2032 (USD Million)
TABLE 164. Global Branded Drug Manufacturers Market Size, by Region, 2017-2032 (USD Million)
TABLE 165. Global Branded Drug Manufacturers Market Size, by Group, 2017-2032 (USD Million)
TABLE 166. Global Branded Drug Manufacturers Market Size, by Country, 2017-2032 (USD Million)
TABLE 167. Global Generic Drug Manufacturers Market Size, by Region, 2017-2032 (USD Million)
TABLE 168. Global Generic Drug Manufacturers Market Size, by Group, 2017-2032 (USD Million)
TABLE 169. Global Generic Drug Manufacturers Market Size, by Country, 2017-2032 (USD Million)
TABLE 170. Global Contract Manufacturing Organizations Market Size, by Region, 2017-2032 (USD Million)
TABLE 171. Global Contract Manufacturing Organizations Market Size, by Group, 2017-2032 (USD Million)
TABLE 172. Global Contract Manufacturing Organizations Market Size, by Country, 2017-2032 (USD Million)
TABLE 173. Global Contract Research Organizations Market Size, by Region, 2017-2032 (USD Million)
TABLE 174. Global Contract Research Organizations Market Size, by Group, 2017-2032 (USD Million)
TABLE 175. Global Contract Research Organizations Market Size, by Country, 2017-2032 (USD Million)
TABLE 176. Global Academic & Research Institutes Market Size, by Region, 2017-2032 (USD Million)
TABLE 177. Global Academic & Research Institutes Market Size, by Group, 2017-2032 (USD Million)
TABLE 178. Global Academic & Research Institutes Market Size, by Country, 2017-2032 (USD Million)
TABLE 179. Global Diagnostic Laboratories Market Size, by Region, 2017-2032 (USD Million)
TABLE 180. Global Diagnostic Laboratories Market Size, by Group, 2017-2032 (USD Million)
TABLE 181. Global Diagnostic Laboratories Market Size, by Country, 2017-2032 (USD Million)
TABLE 182. Global Government & Nonprofit Research Bodies Market Size, by Region, 2017-2032 (USD Million)
TABLE 183. Global Government & Nonprofit Research Bodies Market Size, by Group, 2017-2032 (USD Million)
TABLE 184. Global Government & Nonprofit Research Bodies Market Size, by Country, 2017-2032 (USD Million)
TABLE 185. Global Echinocandin B Market Size, by Region, 2017-2032 (USD Million)
TABLE 186. Asia-Pacific Echinocandin B Market Size, by Region, 2017-2032 (USD Million)
TABLE 187. Asia-Pacific Echinocandin B Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 188. Asia-Pacific Echinocandin B Market Size, by Active Pharmaceutical Ingredient (API), 2017-2032 (USD Million)
TABLE 189. Asia-Pacific Echinocandin B Market Size, by Intermediate For Derivatives, 2017-2032 (USD Million)
TABLE 190. Asia-Pacific Echinocandin B Market Size, by Finished Dosage Form, 2017-2032 (USD Million)
TABLE 191. Asia-Pacific Echinocandin B Market Size, by Route Of Administration, 2017-2032 (USD Million)
TABLE 192. Asia-Pacific Echinocandin B Market Size, by Intravenous, 2017-2032 (USD Million)
TABLE 193. Asia-Pacific Echinocandin B Market Size, by Formulation, 2017-2032 (USD Million)
TABLE 194. Asia-Pacific Echinocandin B Market Size, by Lyophilized Powder, 2017-2032 (USD Million)
TABLE 195. Asia-Pacific Echinocandin B Market Size, by Dosage Regimen, 2017-2032 (USD Million)
TABLE 196. Asia-Pacific Echinocandin B Market Size, by Once Daily, 2017-2032 (USD Million)
TABLE 197. Asia-Pacific Echinocandin B Market Size, by Twice Daily, 2017-2032 (USD Million)
TABLE 198. Asia-Pacific Echinocandin B Market Size, by Packaging, 2017-2032 (USD Million)
TABLE 199. Asia-Pacific Echinocandin B Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 200. Asia-Pacific Echinocandin B Market Size, by Hospital Pharmacy, 2017-2032 (USD Million)
TABLE 201. Asia-Pacific Echinocandin B Market Size, by Application, 2017-2032 (USD Million)
TABLE 202. Asia-Pacific Echinocandin B Market Size, by Therapeutic Development, 2017-2032 (USD Million)
TABLE 203. Asia-Pacific Echinocandin B Market Size, by Commercial Production, 2017-2032 (USD Million)
TABLE 204. Asia-Pacific Echinocandin B Market Size, by Research & Development, 2017-2032 (USD Million)
TABLE 205. Asia-Pacific Echinocandin B Market Size, by Quality Control & Analytics, 2017-2032 (USD Million)
TABLE 206. Asia-Pacific Echinocandin B Market Size, by Diagnostic Use, 2017-2032 (USD Million)
TABLE 207. Asia-Pacific Echinocandin B Market Size, by End User, 2017-2032 (USD Million)
TABLE 208. Asia-Pacific Echinocandin B Market Size, by Pharmaceutical & Biotechnology Companies, 2017-2032 (USD Million)
TABLE 209. North America Echinocandin B Market Size, by Region, 2017-2032 (USD Million)
TABLE 210. North America Echinocandin B Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 211. North America Echinocandin B Market Size, by Active Pharmaceutical Ingredient (API), 2017-2032 (USD Million)
TABLE 212. North America Echinocandin B Market Size, by Intermediate For Derivatives, 2017-2032 (USD Million)
TABLE 213. North America Echinocandin B Market Size, by Finished Dosage Form, 2017-2032 (USD Million)
TABLE 214. North America Echinocandin B Market Size, by Route Of Administration, 2017-2032 (USD Million)
TABLE 215. North America Echinocandin B Market Size, by Intravenous, 2017-2032 (USD Million)
TABLE 216. North America Echinocandin B Market Size, by Formulation, 2017-2032 (USD Million)
TABLE 217. North America Echinocandin B Market Size, by Lyophilized Powder, 2017-2032 (USD Million)
TABLE 218. North America Echinocandin B Market Size, by Dosage Regimen, 2017-2032 (USD Million)
TABLE 219. North America Echinocandin B Market Size, by Once Daily, 2017-2032 (USD Million)
TABLE 220. North America Echinocandin B Market Size, by Twice Daily, 2017-2032 (USD Million)
TABLE 221. North America Echinocandin B Market Size, by Packaging, 2017-2032 (USD Million)
TABLE 222. North America Echinocandin B Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 223. North America Echinocandin B Market Size, by Hospital Pharmacy, 2017-2032 (USD Million)
TABLE 224. North America Echinocandin B Market Size, by Application, 2017-2032 (USD Million)
TABLE 225. North America Echinocandin B Market Size, by Therapeutic Development, 2017-2032 (USD Million)
TABLE 226. North America Echinocandin B Market Size, by Commercial Production, 2017-2032 (USD Million)
TABLE 227. North America Echinocandin B Market Size, by Research & Development, 2017-2032 (USD Million)
TABLE 228. North America Echinocandin B Market Size, by Quality Control & Analytics, 2017-2032 (USD Million)
TABLE 229. North America Echinocandin B Market Size, by Diagnostic Use, 2017-2032 (USD Million)
TABLE 230. North America Echinocandin B Market Size, by End User, 2017-2032 (USD Million)
TABLE 231. North America Echinocandin B Market Size, by Pharmaceutical & Biotechnology Companies, 2017-2032 (USD Million)
TABLE 232. Latin America Echinocandin B Market Size, by Region, 2017-2032 (USD Million)
TABLE 233. Latin America Echinocandin B Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 234. Latin America Echinocandin B Market Size, by Active Pharmaceutical Ingredient (API), 2017-2032 (USD Million)
TABLE 235. Latin America Echinocandin B Market Size, by Intermediate For Derivatives, 2017-2032 (USD Million)
TABLE 236. Latin America Echinocandin B Market Size, by Finished Dosage Form, 2017-2032 (USD Million)
TABLE 237. Latin America Echinocandin B Market Size, by Route Of Administration, 2017-2032 (USD Million)
TABLE 238. Latin America Echinocandin B Market Size, by Intravenous, 2017-2032 (USD Million)
TABLE 239. Latin America Echinocandin B Market Size, by Formulation, 2017-2032 (USD Million)
TABLE 240. Latin America Echinocandin B Market Size, by Lyophilized Powder, 2017-2032 (USD Million)
TABLE 241. Latin America Echinocandin B Market Size, by Dosage Regimen, 2017-2032 (USD Million)
TABLE 242. Latin America Echinocandin B Market Size, by Once Daily, 2017-2032 (USD Million)
TABLE 243. Latin America Echinocandin B Market Size, by Twice Daily, 2017-2032 (USD Million)
TABLE 244. Latin America Echinocandin B Market Size, by Packaging, 2017-2032 (USD Million)
TABLE 245. Latin America Echinocandin B Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 246. Latin America Echinocandin B Market Size, by Hospital Pharmacy, 2017-2032 (USD Million)
TABLE 247. Latin America Echinocandin B Market Size, by Application, 2017-2032 (USD Million)
TABLE 248. Latin America Echinocandin B Market Size, by Therapeutic Development, 2017-2032 (USD Million)
TABLE 249. Latin America Echinocandin B Market Size, by Commercial Production, 2017-2032 (USD Million)
TABLE 250. Latin America Echinocandin B Market Size, by Research & Development, 2017-2032 (USD Million)
TABLE 251. Latin America Echinocandin B Market Size, by Quality Control & Analytics, 2017-2032 (USD Million)
TABLE 252. Latin America Echinocandin B Market Size, by Diagnostic Use, 2017-2032 (USD Million)
TABLE 253. Latin America Echinocandin B Market Size, by End User, 2017-2032 (USD Million)
TABLE 254. Latin America Echinocandin B Market Size, by Pharmaceutical & Biotechnology Companies, 2017-2032 (USD Million)
TABLE 255. Europe Echinocandin B Market Size, by Region, 2017-2032 (USD Million)
TABLE 256. Europe Echinocandin B Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 257. Europe Echinocandin B Market Size, by Active Pharmaceutical Ingredient (API), 2017-2032 (USD Million)
TABLE 258. Europe Echinocandin B Market Size, by Intermediate For Derivatives, 2017-2032 (USD Million)
TABLE 259. Europe Echinocandin B Market Size, by Finished Dosage Form, 2017-2032 (USD Million)
TABLE 260. Europe Echinocandin B Market Size, by Route Of Administration, 2017-2032 (USD Million)
TABLE 261. Europe Echinocandin B Market Size, by Intravenous, 2017-2032 (USD Million)
TABLE 262. Europe Echinocandin B Market Size, by Formulation, 2017-2032 (USD Million)
TABLE 263. Europe Echinocandin B Market Size, by Lyophilized Powder, 2017-2032 (USD Million)
TABLE 264. Europe Echinocandin B Market Size, by Dosage Regimen, 2017-2032 (USD Million)
TABLE 265. Europe Echinocandin B Market Size, by Once Daily, 2017-2032 (USD Million)
TABLE 266. Europe Echinocandin B Market Size, by Twice Daily, 2017-2032 (USD Million)
TABLE 267. Europe Echinocandin B Market Size, by Packaging, 2017-2032 (USD Million)
TABLE 268. Europe Echinocandin B Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 269. Europe Echinocandin B Market Size, by Hospital Pharmacy, 2017-2032 (USD Million)
TABLE 270. Europe Echinocandin B Market Size, by Application, 2017-2032 (USD Million)
TABLE 271. Europe Echinocandin B Market Size, by Therapeutic Development, 2017-2032 (USD Million)
TABLE 272. Europe Echinocandin B Market Size, by Commercial Production, 2017-2032 (USD Million)
TABLE 273. Europe Echinocandin B Market Size, by Research & Development, 2017-2032 (USD Million)
TABLE 274. Europe Echinocandin B Market Size, by Quality Control & Analytics, 2017-2032 (USD Million)
TABLE 275. Europe Echinocandin B Market Size, by Diagnostic Use, 2017-2032 (USD Million)
TABLE 276. Europe Echinocandin B Market Size, by End User, 2017-2032 (USD Million)
TABLE 277. Europe Echinocandin B Market Size, by Pharmaceutical & Biotechnology Companies, 2017-2032 (USD Million)
TABLE 278. Middle East Echinocandin B Market Size, by Region, 2017-2032 (USD Million)
TABLE 279. Middle East Echinocandin B Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 280. Middle East Echinocandin B Market Size, by Active Pharmaceutical Ingredient (API), 2017-2032 (USD Million)
TABLE 281. Middle East Echinocandin B Market Size, by Intermediate For Derivatives, 2017-2032 (USD Million)
TABLE 282. Middle East Echinocandin B Market Size, by Finished Dosage Form, 2017-2032 (USD Million)
TABLE 283. Middle East Echinocandin B Market Size, by Route Of Administration, 2017-2032 (USD Million)
TABLE 284. Middle East Echinocandin B Market Size, by Intravenous, 2017-2032 (USD Million)
TABLE 285. Middle East Echinocandin B Market Size, by Formulation, 2017-2032 (USD Million)
TABLE 286. Middle East Echinocandin B Market Size, by Lyophilized Powder, 2017-2032 (USD Million)
TABLE 287. Middle East Echinocandin B Market Size, by Dosage Regimen, 2017-2032 (USD Million)
TABLE 288. Middle East Echinocandin B Market Size, by Once Daily, 2017-2032 (USD Million)
TABLE 289. Middle East Echinocandin B Market Size, by Twice Daily, 2017-2032 (USD Million)
TABLE 290. Middle East Echinocandin B Market Size, by Packaging, 2017-2032 (USD Million)
TABLE 291. Middle East Echinocandin B Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 292. Middle East Echinocandin B Market Size, by Hospital Pharmacy, 2017-2032 (USD Million)
TABLE 293. Middle East Echinocandin B Market Size, by Application, 2017-2032 (USD Million)
TABLE 294. Middle East Echinocandin B Market Size, by Therapeutic Development, 2017-2032 (USD Million)
TABLE 295. Middle East Echinocandin B Market Size, by Commercial Production, 2017-2032 (USD Million)
TABLE 296. Middle East Echinocandin B Market Size, by Research & Development, 2017-2032 (USD Million)
TABLE 297. Middle East Echinocandin B Market Size, by Quality Control & Analytics, 2017-2032 (USD Million)
TABLE 298. Middle East Echinocandin B Market Size, by Diagnostic Use, 2017-2032 (USD Million)
TABLE 299. Middle East Echinocandin B Market Size, by End User, 2017-2032 (USD Million)
TABLE 300. Middle East Echinocandin B Market Size, by Pharmaceutical & Biotechnology Companies, 2017-2032 (USD Million)
TABLE 301. Africa Echinocandin B Market Size, by Region, 2017-2032 (USD Million)
TABLE 302. Africa Echinocandin B Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 303. Africa Echinocandin B Market Size, by Active Pharmaceutical Ingredient (API), 2017-2032 (USD Million)
TABLE 304. Africa Echinocandin B Market Size, by Intermediate For Derivatives, 2017-2032 (USD Million)
TABLE 305. Africa Echinocandin B Market Size, by Finished Dosage Form, 2017-2032 (USD Million)
TABLE 306. Africa Echinocandin B Market Size, by Route Of Administration, 2017-2032 (USD Million)
TABLE 307. Africa Echinocandin B Market Size, by Intravenous, 2017-2032 (USD Million)
TABLE 308. Africa Echinocandin B Market Size, by Formulation, 2017-2032 (USD Million)
TABLE 309. Africa Echinocandin B Market Size, by Lyophilized Powder, 2017-2032 (USD Million)
TABLE 310. Africa Echinocandin B Market Size, by Dosage Regimen, 2017-2032 (USD Million)
TABLE 311. Africa Echinocandin B Market Size, by Once Daily, 2017-2032 (USD Million)
TABLE 312. Africa Echinocandin B Market Size, by Twice Daily, 2017-2032 (USD Million)
TABLE 313. Africa Echinocandin B Market Size, by Packaging, 2017-2032 (USD Million)
TABLE 314. Africa Echinocandin B Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 315. Africa Echinocandin B Market Size, by Hospital Pharmacy, 2017-2032 (USD Million)
TABLE 316. Africa Echinocandin B Market Size, by Application, 2017-2032 (USD Million)
TABLE 317. Africa Echinocandin B Market Size, by Therapeutic Development, 2017-2032 (USD Million)
TABLE 318. Africa Echinocandin B Market Size, by Commercial Production, 2017-2032 (USD Million)
TABLE 319. Africa Echinocandin B Market Size, by Research & Development, 2017-2032 (USD Million)
TABLE 320. Africa Echinocandin B Market Size, by Quality Control & Analytics, 2017-2032 (USD Million)
TABLE 321. Africa Echinocandin B Market Size, by Diagnostic Use, 2017-2032 (USD Million)
TABLE 322. Africa Echinocandin B Market Size, by End User, 2017-2032 (USD Million)
TABLE 323. Africa Echinocandin B Market Size, by Pharmaceutical & Biotechnology Companies, 2017-2032 (USD Million)
TABLE 324. Global Echinocandin B Market Size, by Group, 2017-2032 (USD Million)
TABLE 325. ASEAN Echinocandin B Market Size, by Group, 2017-2032 (USD Million)
TABLE 326. ASEAN Echinocandin B Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 327. ASEAN Echinocandin B Market Size, by Active Pharmaceutical Ingredient (API), 2017-2032 (USD Million)
TABLE 328. ASEAN Echinocandin B Market Size, by Intermediate For Derivatives, 2017-2032 (USD Million)
TABLE 329. ASEAN Echinocandin B Market Size, by Finished Dosage Form, 2017-2032 (USD Million)
TABLE 330. ASEAN Echinocandin B Market Size, by Route Of Administration, 2017-2032 (USD Million)
TABLE 331. ASEAN Echinocandin B Market Size, by Intravenous, 2017-2032 (USD Million)
TABLE 332. ASEAN Echinocandin B Market Size, by Formulation, 2017-2032 (USD Million)
TABLE 333. ASEAN Echinocandin B Market Size, by Lyophilized Powder, 2017-2032 (USD Million)
TABLE 334. ASEAN Echinocandin B Market Size, by Dosage Regimen, 2017-2032 (USD Million)
TABLE 335. ASEAN Echinocandin B Market Size, by Once Daily, 2017-2032 (USD Million)
TABLE 336. ASEAN Echinocandin B Market Size, by Twice Daily, 2017-2032 (USD Million)
TABLE 337. ASEAN Echinocandin B Market Size, by Packaging, 2017-2032 (USD Million)
TABLE 338. ASEAN Echinocandin B Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 339. ASEAN Echinocandin B Market Size, by Hospital Pharmacy, 2017-2032 (USD Million)
TABLE 340. ASEAN Echinocandin B Market Size, by Application, 2017-2032 (USD Million)
TABLE 341. ASEAN Echinocandin B Market Size, by Therapeutic Development, 2017-2032 (USD Million)
TABLE 342. ASEAN Echinocandin B Market Size, by Commercial Production, 2017-2032 (USD Million)
TABLE 343. ASEAN Echinocandin B Market Size, by Research & Development, 2017-2032 (USD Million)
TABLE 344. ASEAN Echinocandin B Market Size, by Quality Control & Analytics, 2017-2032 (USD Million)
TABLE 345. ASEAN Echinocandin B Market Size, by Diagnostic Use, 2017-2032 (USD Million)
TABLE 346. ASEAN Echinocandin B Market Size, by End User, 2017-2032 (USD Million)
TABLE 347. ASEAN Echinocandin B Market Size, by Pharmaceutical & Biotechnology Companies, 2017-2032 (USD Million)
TABLE 348. GCC Echinocandin B Market Size, by Group, 2017-2032 (USD Million)
TABLE 349. GCC Echinocandin B Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 350. GCC Echinocandin B Market Size, by Active Pharmaceutical Ingredient (API), 2017-2032 (USD Million)
TABLE 351. GCC Echinocandin B Market Size, by Intermediate For Derivatives, 2017-2032 (USD Million)
TABLE 352. GCC Echinocandin B Market Size, by Finished Dosage Form, 2017-2032 (USD Million)
TABLE 353. GCC Echinocandin B Market Size, by Route Of Administration, 2017-2032 (USD Million)
TABLE 354. GCC Echinocandin B Market Size, by Intravenous, 2017-2032 (USD Million)
TABLE 355. GCC Echinocandin B Market Size, by Formulation, 2017-2032 (USD Million)
TABLE 356. GCC Echinocandin B Market Size, by Lyophilized Powder, 2017-2032 (USD Million)
TABLE 357. GCC Echinocandin B Market Size, by Dosage Regimen, 2017-2032 (USD Million)
TABLE 358. GCC Echinocandin B Market Size, by Once Daily, 2017-2032

Companies Mentioned

  • Amneal Pharmaceuticals, Inc.
  • Apotex Inc.
  • Astellas Pharma Inc.
  • Cipla Limited
  • Dr. Reddy’s Laboratories Ltd.
  • F. Hoffmann-La Roche Ltd.
  • Fresenius SE & Co. KGaA
  • Gilead Sciences, Inc.
  • GlaxoSmithKline plc
  • Glenmark Pharmaceuticals Ltd.
  • Hikma Pharmaceuticals PLC
  • Merck & Co., Inc.
  • Novartis AG
  • Pfizer Inc.
  • Sanofi
  • Sun Pharmaceutical Industries Ltd.
  • Teva Pharmaceutical Industries Ltd.
  • Viatris Inc.
  • Wockhardt Limited
  • Zydus Lifesciences Limited

Related Topics

Related Reports

Wood-Based Microcrystalline Cellulose Market - Global Forecast 2026-2032 - Product Image

Wood-Based Microcrystalline Cellulose Market - Global Forecast 2026-2032

  • Report
  • 180 Pages
  • Global
From
Pharmaceutical Grade Polyethylene Glycol Market - Global Forecast 2026-2032 - Product Image

Pharmaceutical Grade Polyethylene Glycol Market - Global Forecast 2026-2032

  • Report
  • 181 Pages
  • Global
From
Excipients - Global Strategic Business Report - Product Image

Excipients - Global Strategic Business Report

  • Report
  • 254 Pages
  • Global
From
High Potency APIs - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts (2026-2031) - Product Image

High Potency APIs - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts (2026-2031)

  • Report
  • 110 Pages
  • Global
From
Tartaric Acid Market Report by End-Use, and Region 2026-2034 - Product Image

Tartaric Acid Market Report by End-Use, and Region 2026-2034

  • Report
  • 147 Pages
  • Global
From
Copyright © 2002-2026 Research and Markets. All Rights Reserved.